{
    "clinical_study": {
        "@rank": "57181", 
        "acronym": "CARE", 
        "arm_group": [
            {
                "arm_group_label": "PC 400"
            }, 
            {
                "arm_group_label": "Conventional Embolic Coils", 
                "description": "These are any approved embolic coils on the market used as part of the standard of care for treating intracranial aneurysms."
            }
        ], 
        "brief_summary": {
            "textblock": "The primary objective of this study is to gather data on the radiation exposure in patients\n      treated with the Penumbra Coil 400\u2122 System (PC 400) or conventional coils per their\n      respective indications for use.This is a multicenter case review study of patients\n      presenting with intracranial aneurysms who are treated with coil embolization therapy using\n      the PC 400 or conventional coils.  Data for each patient are collected acutely.Up to 90\n      patients treated with the PC 400 or conventional coils (2:1) at up to 15 centers in the USA\n      will be enrolled."
        }, 
        "brief_title": "CARE: A Multicenter Case Study to Assess Radiation Exposure in Patients Treated With the Penumbra Coil 400", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Intracranial Aneurysms", 
        "condition_browse": {
            "mesh_term": [
                "Aneurysm", 
                "Intracranial Aneurysm"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients enrolled in the PC 400 arm must be those treated according to the cleared\n             indication for the PC 400 System, which includes endovascular embolization of\n             intracranial aneurysms.\n\n          -  Patients treated with conventional coils should be treated per their IFU.\n\n          -  Adjunctive use of stents, balloons or liquid embolics, if considered appropriate by\n             investigators, is allowed.\n\n        Exclusion Criteria:\n\n          -  Pre-planned use of multiple coil systems and/or flow diverters."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Up to 90 patients treated with the PC 400 or conventional coils (2:1) at up to 15 centers\n        in the USA will be enrolled."
            }
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02122133", 
            "org_study_id": "CLP 7495"
        }, 
        "intervention": {
            "arm_group_label": [
                "PC 400", 
                "Conventional Embolic Coils"
            ], 
            "intervention_name": "PC 400", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": "IC aneurysms, coil embolization, PC 400, radiation exposure,", 
        "lastchanged_date": "April 22, 2014", 
        "location": {
            "contact": {
                "email": "minkuc@gmail.com", 
                "last_name": "Chowdhary Chowdhary, MD", 
                "phone": "425-635-6300"
            }, 
            "facility": {
                "address": {
                    "city": "Bellevue", 
                    "country": "United States", 
                    "state": "Washington", 
                    "zip": "98004"
                }, 
                "name": "Overlake Hospital Medical Center"
            }, 
            "investigator": {
                "last_name": "Abhineet Chowdhary, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "CARE: A Multicenter Case Study to Assess Radiation Exposure in Patients Treated With the Penumbra Coil 400", 
        "overall_contact": {
            "email": "minkuc@gmail.com", 
            "last_name": "Abhineet Chowdhary, MD"
        }, 
        "overall_official": {
            "affiliation": "Director of Neuro-Interventional Surgery, Overlake Hospital Medical Center, Bellevue, WA 98004", 
            "last_name": "Abhineet Chowdhary, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Overlake Hospital IRB", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Radiation exposure is measured by air kerma, kerma-area product (KAP) or dose area product (DAP), and fluoroscopic time.", 
                "measure": "1. Acute radiation exposure [air kerma, kerma-area product (KAP) or dose area product (DAP), and fluoroscopic time].", 
                "safety_issue": "Yes", 
                "time_frame": "At immediate post-procedure"
            }, 
            {
                "measure": "2. Procedural serious adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Procedural serious adverse events up until 3 days or discharge, whichever occurs first."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02122133"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Penumbra Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Penumbra Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "3 Days", 
        "verification_date": "April 2014"
    }
}